ANUH PHARMA
Back to Cashflow Statement
|
ANUH PHARMA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-4.86 Cr | ₹-8.57 Cr | ₹-12 Cr | ₹-19 Cr | ₹-33 Cr |
What is the latest Cash Flow from Financing Activities ratio of ANUH PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-4.86 Cr |
| Mar2024 | ₹-8.57 Cr |
| Mar2023 | ₹-12 Cr |
| Mar2022 | ₹-19 Cr |
| Mar2021 | ₹-33 Cr |
How is Cash Flow from Financing Activities of ANUH PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.86 Cr | Negative | |
| Mar2024 | ₹-8.57 Cr | Negative | |
| Mar2023 | ₹-12 Cr | Negative | |
| Mar2022 | ₹-19 Cr | Negative | |
| Mar2021 | ₹-33 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹798.6 Cr | -3.8% | 18.7% | -5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -3.8% |
18.7% |
-5.5% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses